Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206–8215]. Issue 36 (23rd August 2021)

Record Type:: Journal Article
Title:: Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206–8215]. Issue 36 (23rd August 2021)
Main Title:: Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206–8215]
Authors:: Rosenthal, Elizabeth M.
Hall, Eric W.
Rosenberg, Eli S.
Harris, Aaron
Nelson, Noele P.
Schillie, Sarah
Abstract:
Is Part Of:: Vaccine. Volume 39:Issue 36(2021)
Journal:: Vaccine
Issue:: Volume 39:Issue 36(2021)
Issue Display:: Volume 39, Issue 36 (2021)
Year:: 2021
Volume:: 39
Issue:: 36
Issue Sort Value:: 2021-0039-0036-0000
Page Start:: 5231
Page End:
Publication Date:: 2021-08-23
Subjects:: Vaccines -- Periodicals
615.372
Journal URLs:: http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.vaccine.2021.07.070 ↗
Languages:: English
ISSNs:: 0264-410X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 18471.xml